Development and Validation of a Medical Chart Review Checklist for Symptom Management Performance of Oncologists in the Routine Care of Patients With Advanced Cancer

Abstract Context Oncologists perform a range of pharmacological and nonpharmacological interventions to manage the symptoms of outpatients with advanced cancer. Objectives The aim of this study was to develop and test a symptom management performance checklist (SyMPeC) to review medical charts. Meth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pain and symptom management 2014-12, Vol.48 (6), p.1160-1167
Hauptverfasser: Blum, David, MD, Rosa, Daniel, MD, deWolf-Linder, Susanne, RN, Hayoz, Stefanie, PhD, Ribi, Karin, PhD, Koeberle, Dieter, MD, Strasser, Florian, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Context Oncologists perform a range of pharmacological and nonpharmacological interventions to manage the symptoms of outpatients with advanced cancer. Objectives The aim of this study was to develop and test a symptom management performance checklist (SyMPeC) to review medical charts. Methods First, the content of the checklist was determined by consensus of an interprofessional team. The SyMPeC was tested using the data set of the SAKK 96/06 E-MOSAIC (Electronical Monitoring of Symptoms and Syndromes Associated with Cancer) trial, which included six consecutive visits from 247 patients. In a test data set (half of the data) of medical charts, two people extracted and quantified the definitions of the parameters (content validity). To assess the inter-rater reliability, three independent researchers used the SyMPeC on a random sample (10% of the test data set), and Fleiss's kappa was calculated. To test external validity, the interventions retrieved by the SyMPeC chart review were compared with nurse-led assessment of patient-perceived oncologists' palliative interventions. Results Five categories of symptoms were included: pain, fatigue, anorexia/nausea, dyspnea, and depression/anxiety. Interventions were categorized as symptom specific or symptom unspecific. In the test data set of 123 patients, 402 unspecific and 299 symptom-specific pharmacological interventions were detected. Nonpharmacological interventions ( n  = 242) were mostly symptom unspecific. Fleiss's kappa for symptom and intervention detections was K  = 0.7 and K  = 0.86, respectively. In 1003 of 1167 visits (86%), there was a match between SyMPeC and nurse-led assessment. Seventy-nine percent (195 of 247) of patients had no or one mismatch. Conclusion Chart review by SyMPeC seems reliable to detect symptom management interventions by oncologists in outpatient clinics. Nonpharmacological interventions were less symptom specific. A template for documentation is needed for standardization.
ISSN:0885-3924
1873-6513
DOI:10.1016/j.jpainsymman.2014.04.009